Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
26 24 Search
2025
Overexpression of long non‑coding RNA H19 enhances cell viability and inhibits apoptosis in recurrent spontaneous abortion by targeting the miR-29a-3p/SOCS3 axis
In Vitro Cellular & Developmental Biology - Animal
2025
The Role and Clinical Application of miR-29a-3p in the Development and Progression of Malignant Tumors
Journal of Clinical Personalized Medicine
2025
Analysing the relevance of TGF-β and its regulators in cervical cancer to identify therapeutic and diagnostic markers
Gene
2024
The clinical utilization of SNIP1 and its pathophysiological mechanisms in disease
Heliyon
2024
Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine
Biomedicines
2024
Tumour-regulatory role of long non-coding RNA HOXA-AS3
Progress in Biophysics and Molecular Biology
2024
The lncRNA H19/miR-29a-3p/SNIP1/c-myc regulatory axis is involved in pulmonary fibrosis induced by Nd2O3
Toxicological Sciences
2023
Silencing of the circ-Arhgap5 RNA protects neuronal PC12 cells against injury and depends on the miR-29a-3p/Rock1 axis
Metabolic Brain Disease
2023
MiR‐138‐5p suppresses the progression of lung cancer by targeting SNIP1
Thoracic Cancer
2023
The role and clinical significance of microRNA-29a-3p in the development of hypopharyngeal carcinoma
Brazilian Journal of Otorhinolaryngology
2022
Circ_0072995 drives cervical cancer development by regulating the miR-29a/WDR5 axis
Journal of Obstetrics and Gynaecology
2022
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma
International Journal of Molecular Sciences
2022
Prognostic value of lncRNA HOXA‐AS3 in cervical cancer by targeting miR‐29a‐3p and its regulatory effect on tumor progression
Journal of Obstetrics and Gynaecology Research
2022
C1QTNF6 regulated by miR‐29a-3p promotes proliferation and migration in stage I lung adenocarcinoma
BMC Pulmonary Medicine
2022
MiR-29a-3p Inhibits Proliferation and Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells via Targeting FOXO3 and Repressing Wnt/β-Catenin Signaling in Steroid-Associated Osteonecrosis
International Journal of Stem Cells
2022
Angelol-A exerts anti-metastatic and anti-angiogenic effects on human cervical carcinoma cells by modulating the phosphorylated-ERK/miR-29a-3p that targets the MMP2/VEGFA axis
Life Sciences
2022
Exosomal-microRNA transcriptome profiling of Parental and CSC-like MDA-MB-231 cells in response to cisplatin treatment
Pathology - Research and Practice
2022
MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer
Clinical and Translational Oncology
2022
Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects
Biomedicines
2022
miR‑29a‑3p inhibits the malignant characteristics of non‑small cell lung cancer cells by reducing the activity of the Wnt/β‑catenin signaling pathway
Oncology Letters
2022
Human Bone Marrow Mesenchymal Stem Cell (hBMSCs)-Derived miR-29a-3p-Containing Exosomes Impede Laryngocarcinoma Cell Malignant Phenotypes by Inhibiting PTEN
Stem Cells International
2021
miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1
BMC Cancer
2021
Development and Validation of a Prognostic Model of RNA-Binding Proteins in Colon Adenocarcinoma: A Study Based on TCGA and GEO Databases
Cancer Management and Research
2021
Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis
PeerJ
2021
Upregulation of miR-29a suppressed the migration and invasion of trophoblasts by directly targeting LOXL2 in preeclampsia
Journal of Hypertension
Additional cited-by details will be shown when available from Crossref